Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading…
Optimism for AI-powered drug discovery is rising as industry giants, startups, and even Sam Altman step up investments Read More: Big Pharma is ready for its…
Q: How is the pace and quality of enrollment in Asia compared to the US? A: The pace of enrollment in Asia is about 2 to…
SEIZED OZEMPIC, WEGOVY AND OTHER WEIGHT LOSS DRUGS AT JFK AIRPORT’S INTERNATIONAL MAIL FACILITY.CNBCCOPENHAGEN, Denmark — Europe’s pharmaceutical sector is bracing for the potential impact of…
“So, there is uncertainty. I definitely agree. And as you said that there is de-globalisation, there is a tariff threat which is there,” says Milind Karmarkar,…
The week’s investing action plan includes a strong dose of pharma and biotech earnings, January econ reports, plus Amazon and Alphabet. Read More: Investing Action Plan:…
The U.S. Supreme Court on Thursday rejected a nationwide settlement with OxyContin maker Purdue Pharma that would have shielded members of the Sackler family who own…
Shares of Pfizer Inc. and other biotech drug makers fell in the extended session Friday after Pfizer slashed $9 billion in expected sales from its full-year…